Psychotropic drugs: Selective Serotonin Reuptake Inhibitors

Further Reading

• Arch Pediatr Adolesc Med. 2002 Nov;156(11):1129-32.
  Costei AM, Kozer E, Ho T, Ito S, Koren G: Perinatal outcome following third trimester exposure to paroxetine.
• Arch Dis Child Fetal Neonatal Ed 2001; 84:F134-F135.
  Stiskal JA, Kulin N, Koren G, Ho T, Ito S: Neonatal paroxetine withdrawal syndrome.
• Psychol Med. 2000 Jan;30(1):89-94.
  Addis A, Koren G: Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.
• Depress Anxiety. 1998;8 Suppl 1:27-31. No abstract available.
  Koren G, Nulman I, Addis A: Outcome of children exposed in utero to fluoxetine: a critical review.
• JAMA. 279(8):609-10, 1998 Feb 25.
  Kulin NA et al: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors
• Canadian Family Physician. 42:43-4, 1996 Jan. No abstract available.
  Koren G: First-trimester exposure to fluoxetine (prozac). Does it affect pregnancy outcome?.
• JAMA 269: 2246-2248, 1993.
  Pastuszak A et al: Pregnancy outcome following first trimester exposure to fluoxetine.
• Teratology 53: 304-308, 1996. No abstract available.
  Nulman I, Koren G: The safety of fluoxetine during pregnancy and lactation.
• Can Fam Physicians 42: 43-44, 1995. No abstract available.
  Koren G: First trimester exposure to fluoxetine.